Healthy Skepticism Library item: 18944

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: news

Hunkar D
The Top 20 Global Pharmaceuticals by Sales
Seeking Alpha 2010 Nov 21
http://seekingalpha.com/article/237967-the-top-20-global-pharmaceuticals-by-sales

Full text:

The table below lists the top 20 global drug companies based on sales in 2009:

S.No. Company Ticker 2009 Revenues in US $ (Milllions)
1 Pfizer PFE $45,448
2 Sanofi-Aventis SNY $40,871
3 Novartis NVS $38,455
4 GlaxoSmithKline GSK $36,746
5 AstraZeneca AZN $31,905
6 Merck & Co. MRK $26,929
7 Johnson & Johnson JNJ $22,520
8 Eli Lilly & Co. LLY $20,629
9 Bristol-Myers Squibb BMY $18,808
10 Abbott Laboratories ABT $16,486
11 Takeda Chem Ind. TKPHY.PK $14,204
12 Boehringer-Ingelheim $14,027
13 Teva Pharma TEVA $13,814
14 Bayer Schering BAYRY.PK $13,344
15 Astellas ALPMY.PK $10,509
16 Daiichi-Sankyo DSKYY.PK $9,757
17 Eisai ESALY.PK $8,441
18 Otsuka $7,717
19 Gilead Sciences GILD $6,469
20 Mylan MYL $5,015
Source: Contract Pharma

Otsuka, Gilead and Mylan are new to this list. Half of the companies ranked 11-20 are based in Japan. Though currently ranked at number 13, Israel-based Teva (TEVA), the world’s largest generic drug maker, has revenue goals that could propel it into the top 7 ranks in the next few years. U.S.-based Gilead (GILD) primarily focuses on developing drugs for life-threatening diseases diseases such as HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.